Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Benitec Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BNTC
Nasdaq
8731
https://benitec.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Benitec Biopharma Inc
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
- Apr 18th, 2024 11:30 am
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
- Apr 18th, 2024 11:00 am
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024
- Apr 9th, 2024 12:00 pm
11 Best ASX Stocks To Buy Now
- Mar 24th, 2024 11:55 am
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
- Feb 13th, 2024 1:00 pm
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
- Nov 30th, 2023 12:00 pm
Here's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Compensation Is The Least Of Shareholders Concerns
- Nov 30th, 2023 10:06 am
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference
- Nov 17th, 2023 1:00 pm
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
- Nov 13th, 2023 1:00 pm
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update
- Sep 21st, 2023 12:00 pm
Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc
- Aug 22nd, 2023 1:02 am
JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc
- Aug 19th, 2023 1:02 am
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
- Aug 11th, 2023 5:00 pm
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
- Aug 9th, 2023 2:30 am
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
- Jul 25th, 2023 5:00 pm
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
- Jun 26th, 2023 12:00 pm
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
- May 15th, 2023 12:00 pm
Benitec Biopharma to Present at the OPMD International Conference
- May 8th, 2023 12:05 pm
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
- May 8th, 2023 12:00 pm
Scroll